Post by
Jon9800 on Jun 28, 2022 10:13am
$HEM grants worldwide field license to PreCerv Inc.
Hemostemix recently granted the global field license of use of NCP-01 and its autologous stem cell therapies to PreCerv Inc. its wholly owned subsidiary to aid patients with peripheral and central nervous system conditions.